318 related articles for article (PubMed ID: 30646938)
1. High incidence of type III secretion system associated virulence factors (exoenzymes) in Pseudomonas aeruginosa isolated from Iranian burn patients.
Khodayary R; Nikokar I; Mobayen MR; Afrasiabi F; Araghian A; Elmi A; Moradzadeh M
BMC Res Notes; 2019 Jan; 12(1):28. PubMed ID: 30646938
[TBL] [Abstract][Full Text] [Related]
2. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
Park MH; Kim SY; Roh EY; Lee HS
Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates.
Jarjees KK
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.
Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M
Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427
[TBL] [Abstract][Full Text] [Related]
5. The frequency of genes encoding exotoxin A and exoenzyme S in Pseudomonas aeruginosa strains isolated from burn patients.
Khosravi AD; Shafie F; Abbasi Montazeri E; Rostami S
Burns; 2016 Aug; 42(5):1116-1120. PubMed ID: 27263417
[TBL] [Abstract][Full Text] [Related]
6. [Carriage of the Pseudomonas aeruginosa virulence factors and prognosis after infection].
Zhao RZ; Zheng YJ; Chen Q
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):672-7. PubMed ID: 23158816
[TBL] [Abstract][Full Text] [Related]
7. Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections.
Haghi F; Zeighami H; Monazami A; Toutouchi F; Nazaralian S; Naderi G
Microb Pathog; 2018 Feb; 115():251-256. PubMed ID: 29273509
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia.
Garey KW; Vo QP; Larocco MT; Gentry LO; Tam VH
J Chemother; 2008 Dec; 20(6):714-20. PubMed ID: 19129069
[TBL] [Abstract][Full Text] [Related]
9. High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals.
Horna G; Amaro C; Palacios A; Guerra H; Ruiz J
Sci Rep; 2019 Jul; 9(1):10874. PubMed ID: 31350412
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of Cinnamaldehyde, Carvacrol, and honey on the expression of exoS and ampC genes in multidrug-resistant Pseudomonas aeruginosa isolated from burn wound infections.
Mohammadzamani Z; Khorshidi A; Khaledi A; Shakerimoghaddam A; Moosavi GA; Piroozmand A
Microb Pathog; 2020 Mar; 140():103946. PubMed ID: 31874231
[TBL] [Abstract][Full Text] [Related]
12. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
Shi H; Chen Z; Kan J
Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
[TBL] [Abstract][Full Text] [Related]
13. Presence of T3SS (exoS, exoT, exoU and exoY), susceptibility pattern and MIC of MDR-Pseudomonas aeruginosa from burn wounds.
Ullah R; Amir M; Anjum S; Ur Rehman M; Noorul Hasan T; Sajjad Naqvi S; Faryal R; Ali Khan H; Khadija B; Arshad N; Rashid Z; Yousaf M; Ammad M; Mazhar K
J Infect Dev Ctries; 2023 Aug; 17(8):1130-1137. PubMed ID: 37699096
[TBL] [Abstract][Full Text] [Related]
14. The Prevalence of Exoenzyme S Gene in Multidrug-Sensitive and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains.
Bogiel T; Deptuła A; Kwiecińska-Piróg J; Prażyńska M; Mikucka A; Gospodarek-Komkowska E
Pol J Microbiol; 2017 Dec; 66(4):427-431. PubMed ID: 29313517
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of type III Pseudomonas aeruginosa bacteremia.
El-Solh AA; Hattemer A; Hauser AR; Alhajhusain A; Vora H
Crit Care Med; 2012 Apr; 40(4):1157-63. PubMed ID: 22080633
[TBL] [Abstract][Full Text] [Related]
16. Molecular detection of six virulence genes in Pseudomonas aeruginosa isolates detected in children with urinary tract infection.
Badamchi A; Masoumi H; Javadinia S; Asgarian R; Tabatabaee A
Microb Pathog; 2017 Jun; 107():44-47. PubMed ID: 28315724
[TBL] [Abstract][Full Text] [Related]
17. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance, biofilm-forming ability and virulence potential of Pseudomonas aeruginosa isolated from burn patients in northern Iran.
Asadpour L
J Glob Antimicrob Resist; 2018 Jun; 13():214-220. PubMed ID: 29421318
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of virulence-related genes of type III secretion system of Pseudomonas aeruginosa].
Zhuo C; Wang LX; Xiao SN; Li HY; Qiu GX; Zhong NS
Zhonghua Shao Shang Za Zhi; 2010 Oct; 26(5):354-9. PubMed ID: 21162783
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Virulence Genes Associated with Type III Secretion System and Biofilm Formation in Pseudomonas aeruginosa Clinical Isolates.
Ali ASBE; Ozler B; Baddal B
Curr Microbiol; 2023 Oct; 80(12):389. PubMed ID: 37880467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
